Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ensysce Biosciences (ENSC) Net Income towards Common Stockholders: 2018-2025

Historic Net Income towards Common Stockholders for Ensysce Biosciences (ENSC) over the last 7 years, with Jun 2025 value amounting to -$1.7 million.

  • Ensysce Biosciences' Net Income towards Common Stockholders rose 11.91% to -$1.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$6.6 million, marking a year-over-year increase of 41.64%. This contributed to the annual value of -$8.0 million for FY2024, which is 24.83% up from last year.
  • According to the latest figures from Q2 2025, Ensysce Biosciences' Net Income towards Common Stockholders is -$1.7 million, which was up 10.91% from -$1.9 million recorded in Q1 2025.
  • Over the past 5 years, Ensysce Biosciences' Net Income towards Common Stockholders peaked at $661,769 during Q3 2024, and registered a low of -$17.2 million during Q3 2021.
  • For the 3-year period, Ensysce Biosciences' Net Income towards Common Stockholders averaged around -$2.2 million, with its median value being -$2.2 million (2023).
  • Per our database at Business Quant, Ensysce Biosciences' Net Income towards Common Stockholders slumped by 5,165.56% in 2021 and then surged by 124.61% in 2024.
  • Quarterly analysis of 5 years shows Ensysce Biosciences' Net Income towards Common Stockholders stood at -$10.8 million in 2021, then soared by 49.06% to -$5.5 million in 2022, then spiked by 36.54% to -$3.5 million in 2023, then dropped by 1.72% to -$3.6 million in 2024, then climbed by 11.91% to -$1.7 million in 2025.
  • Its last three reported values are -$1.7 million in Q2 2025, -$1.9 million for Q1 2025, and -$3.6 million during Q4 2024.